Showing results (201-210 of 257) with videos related to
Sort By:
Pageof 26
European Journal of Obstetrics, Gynecology, and Reproductive Biology|April 17, 1999
Differences between hereditary and sporadic ovarian cancerR P Zweemer, R H Verheijen, F H Menko, et al.European Journal of Immunology|June 1, 1993
Identification of peptide sequences that potentially trigger HLA-A2.1-restricted cytotoxic T lymphocytesH W Nijman, J G Houbiers, M P Vierboom, et al.Journal of Internal Medicine|March 12, 2002
Oral oestradiol/trimegestone replacement reduces procarboxypeptidase U (TAFI): a randomized, placebo- controlled, 12-week study in early postmenopausal womenM S Post, D F Hendriks, M J Van Der Mooren, et al.International Journal of Cancer|April 3, 2001
Influence of the route of administration on targeting of ovarian cancer with the chimeric monoclonal antibody MOv18: i.v. vs. i.pI van Zanten-Przybysz, C F Molthoff, J C Roos, et al.Clinical Chemistry|June 1, 1993
Evaluation of colorectal cancer-associated mucin CA M43 assay in serumG J van Kamp, S von Mensdorff-Pouilly, P Kenemans, et al.Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 1992
Use of serum tumor markers in the differential diagnosis between ovarian and colorectal adenocarcinomasC A Yedema, P Kenemans, T Wobbes, et al.British Journal of Cancer|June 1, 1994
Differences in MHC and TAP-1 expression in cervical cancer lymph node metastases as compared with the primary tumoursF V Cromme, P F van Bommel, J M Walboomers, et al.Cancer Immunology, Immunotherapy : CII|May 11, 1999
Cellular and humoral immune responses to MUC1 mucin and tandem-repeat peptides in ovarian cancer patients and controlsF G Snijdewint, S von Mensdorff-Pouilly, A H Karuntu-Wanamarta, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 1, 1990
Immunoscintigraphy of ovarian cancer with indium-111-labeled OV-TL 3 F(ab')2 monoclonal antibodyL F Massuger, P Kenemans, R A Claessens, et al.Journal of the National Cancer Institute|May 1, 1986
Monoclonal antibody against human ovarian tumor-associated antigensL G Poels, D Peters, Y van Megen, et al.Pageof 26